logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Haukeland hospital

+4755975000
postmottak@helse-bergen.no
Source: Site record.
https://helse-bergen.no

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Haukeland University Hospital is the largest hospital in Norway by patient volume and one of the region's primary employers with approximately 14,000 workers. Founded in 1912, it functions as the local medical center for Bergen and surrounding municipalities, the central facility for Vestland county, and a highly specialized regional and national resource center. The public teaching hospital operates in close partnership with the University of Bergen to advance medical research and education.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Google. Hospital
Source: Trial-derived.
79Total Trials
Source: Trial-derived.
21Recruiting Trials
Source: Trial-derived.
28Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
121Unique Conditions
Source: Trial-derived.
107Unique Sponsors

Conditions

Source: Trial-derived. Fabry Disease (5)Source: Trial-derived. Acute Myeloid Leukemia (3)Source: Trial-derived. Multiple Sclerosis (3)Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Acute Myeloid Leukemia, Adult (2)Source: Trial-derived. Anxiety (2)Source: Trial-derived. Breast Neoplasms (2)Source: Trial-derived. Cystic Fibrosis (2)

Sponsors

Source: Trial-derived. Haukeland University Hospital (29)Source: Trial-derived. University of Bergen (10)Source: Trial-derived. Chiesi Farmaceutici S.p.A. (5)Source: Trial-derived. Oslo University Hospital (5)Source: Trial-derived. The Research Council of Norway (5)Source: Trial-derived. Helse Stavanger HF (4)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Stichting Hemato-Oncologie voor Volwassenen Nederland (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. Spirometry
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. PET-CT
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Stereotactic body radiotherapy (SBRT)
Source: AI-inferred. Supplemental oxygen administration
Source: AI-inferred. Sweat chloride testing